| Tag | Content |
|---|
EnhancerAtlas ID | HS151-00343 |
Organism | Homo sapiens |
Tissue/cell | OCI-LY1 |
Coordinate | chr1:36722600-36723560 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| FOSL2 | MA0478.1 | chr1:36723189-36723200 | GGGTGACTCAG | + | 6.02 | | JUNB | MA0490.1 | chr1:36723189-36723200 | GGGTGACTCAG | + | 6.02 | | Zfx | MA0146.2 | chr1:36722641-36722655 | CCCGCCTCGGCCTC | + | 6.01 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_48396 | chr1:36721990-36724805 | Psoas_Muscle | | SE_51263 | chr1:36721937-36725877 | Skeletal_Muscle |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I036257 | chr1 | 36722658 | 36725010 |
|
Enhancer Sequence | TTGGTCAGGC TGGTCTTGAA CTCCCGACCT CAGGTGATCT GCCCGCCTCG GCCTCCCAAA 60
GTGGTGGGAT TACAGGTGTG AGCCACCGCG CTTGGCCAAC ATTGCAGACA TTCTTATTTT 120
TGTCTCTTCC TCAGACAGTC AGGCATGTTT CCTCCCCAGG GTCTTTGCAT TTGCTGTTTC 180
CTCAGATAAG GCCCAGTATA CTCTTTTTCT TCCGTCTCTG CTCAGCTGTC TCATGAGAGA 240
GGCCTTCCCT TAATGCGTGA TATAAAATTG TATAACTTTT ACTCCTCCAG GTGCCCTCAT 300
CTGCTCACTA GAATGTCAGT TCCAGGCATG AAGGGACTTT TAAATTATTG AACCTCCAGT 360
GTTTAGAATA GTGCCTGGCA TGTAGTCAGT ACTTAATAAA TTATTTGTTG AATAAGTGGA 420
CAATTAGTAA TGTGTAGAAG GGAAGAGGGT CTATTGTGGA GTCTCCTTGC TAATACACTG 480
CTGTTTGGCC AAAGGAGGTT CAGGAGATAG AGGCTGACAA GTATGCCTGT GGCTGGCCAG 540
ATGACATGCA GGACAGGCTA GGCAGGAGGA GGGCAACTGT GGTGGCAGGG GGTGACTCAG 600
GGTTTCAGGT GTCTCTTCGC TGTCACAGAG TAACTAAAGG CCAGAGCCTC AGATTTGCTT 660
ATTCACTCAT CGCAACAATG GGGAATTGAA GACTTGTTGG AATGATAAAA TTCTTGCCAA 720
TATCCAAGAA GAGGTTAATT AATAGGAAAT ATGATGGAGT AATAAAATGG GAGATTTATG 780
TGTGTGTACT TTTGCCATCT GGTTAGAATT AGAGGGAAAG ATGGATGTAT TGGAATAGAT 840
TGTGTTTTTT TGTTGTTTTG AGACAGAGTC TCGCTCTGTC ACCCACGCTG GAGTGCAATG 900
GCACGATCTC GGCACACTGC AACCTCTGCT TCCCGAGTTC AAGGGATTCT CCTGCCTCAG 960
|
